INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

76,653 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.48M
21.3K sh
May 1, 2026May 1, 2026
Page 1025 of 1917
← PrevNext →
traded May 1, 2026
+0d
SEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$226K
2,080 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
520 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$1.33M
47.2K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

26
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$112K
8,457 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

26
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
8,458 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$190K
1,760 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$203K
1,840 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
YM
Young Tobi M.Director
HALHALLIBURTON CO
Open-market sale
SELL$21K
500 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$51K
460 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

25
Lizzie FletcherDSelf
AMPAMERIPRISE FINANCIAL INC
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

25
CD
Cox John DDirector
NWWPNEW PEOPLES BANKSHARES INC
Open-market purchase
BUY$33K
8,570 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

25
Lizzie FletcherDSelf
JPMJPMORGAN CHASE & CO
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

25
SM
Schmidt MarianneEXECUTIVE OFFICER
EFSIEAGLE FINANCIAL SERVICES INC
Open-market sale
SELL$15K
388 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

24
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$932K
12.8K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

24
DV
DiVito Joseph V. JrDirector
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Grant or award
A$51K
2,790 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

24
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$628K
8,777 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

23
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
440 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

23
HA
Hardy AndrewEVP, Chief Sales Officer
NXPINXP Semiconductors N.V.
Tax withholding
F$718K
2,483 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

23
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$562K
20.0K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

22
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$30K
400 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

22
PR
Palmer Stephen RVice President of Accounting
CVNACARVANA CO.
Open-market sale · 10b5-1 plan
SELL$395K
1,000 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

21
EA
Edwards Shirley AnnDirector
SOLVSolventum Corp
Option exercise
M—
3,403 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

21
NR
Naya Barba RicardoEVP Sust., Ops. & Ventures
CXCEMEX SAB DE CV
Grant or award
A—
72.4K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

21
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Grant or award
A—
100.1K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

21
GC
Glessner ColeenEVP, Quality & Ethics, and CPL
EBSEmergent BioSolutions Inc.
Grant or award
A—
100.1K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

21
PJ
Perl JessicaSVP, General Counsel, Corp Sec
EBSEmergent BioSolutions Inc.
Grant or award
A—
104.3K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

21
PM
Prince John MichaelDirector
CTEVClaritev Corp
Grant or award
A—
8,977 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

21
BJ
Bailey Richard J JrDirector
LADLITHIA MOTORS INC
Grant or award
A—
715 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

21
LC
Lowry Simon CSVP, R&D, CMO
EBSEmergent BioSolutions Inc.
Grant or award
A—
100.1K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

21
SR
Sotomayor RafaelCEO & President
NXPINXP Semiconductors N.V.
Option exercise
M—
1,095 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

21
MM
Menendez Sergio MauricioPresident of Cemex Mexico
CXCEMEX SAB DE CV
Grant or award
A—
82.3K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

21
KL
Kap Jason LamarDirector
CTEVClaritev Corp
Grant or award
A—
8,977 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

21
ME
Mily ElizabethDirector
SOLVSolventum Corp
Option exercise
M—
3,403 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

21
EB
Elizondo de la Garza Oscar BalmoreVP of Global Ent. Services
CXCEMEX SAB DE CV
Grant or award
A—
19.6K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

21
MJ
Muguiro Dominguez JaimeChief Executive Officer
CXCEMEX SAB DE CV
Grant or award
A—
333.6K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

21
GA
Gonzalez Flores Jose AntonioEVP Strat. Plan. & Bus. Dev.
CXCEMEX SAB DE CV
Grant or award
A—
74.1K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

21
SR
Saldana Madero RogerSenior Vice President of Legal
CXCEMEX SAB DE CV
Grant or award
A—
37.1K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

21
RA
Ramirez Cantu Alejandro AlbertoPresident of Cemex SCA&C
CXCEMEX SAB DE CV
Grant or award
A—
50.1K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

21
HW
Hartzel WilliamSVP, Bioservices
EBSEmergent BioSolutions Inc.
Grant or award
A—
100.1K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence